Literature DB >> 31066605

Effect of levodopa on electroencephalographic biomarkers of the parkinsonian state.

Andrew M Miller1,2, Svjetlana Miocinovic3, Nicole C Swann4, Sheila S Rajagopalan1, David M Darevsky1,5, Ro'ee Gilron1, Coralie de Hemptinne1, Jill L Ostrem6,7, Philip A Starr1,7,5.   

Abstract

The objective of this study was to evaluate proposed electroencephalographic (EEG) biomarkers of Parkinson's disease (PD) and test their correlation with motor impairment in a new, well-characterized cohort of PD patients and controls. Sixty-four-channel EEG was recorded from 14 patients with rigid-akinetic PD with minimal tremor and from 14 age-matched healthy controls at rest and during voluntary movement. Patients were tested off and on medication during a single session. Recordings were analyzed for phase-amplitude coupling over sensorimotor cortex and for pairwise coherence from all electrode pairs in the recording montage (distributed coherence). Phase-amplitude coupling and distributed coherence were found to be elevated Off compared with On levodopa, and their reduction was correlated with motor improvement. In the Off medication state, phase-amplitude coupling was greater in sensorimotor contacts contralateral to the most affected body part and reduced by voluntary movement. We conclude that phase-amplitude coupling and distributed coherence are cortical biomarkers of the parkinsonian state that are detectable noninvasively and may be useful as objective aids for management of dopaminergic therapy. Several analytic methods may be used for noninvasive measurement of abnormal brain synchronization in PD. Calculation of phase-amplitude coupling requires only a single electrode over motor cortex. NEW & NOTEWORTHY Several EEG biomarkers of the parkinsonian state have been proposed that are related to abnormal cortical synchronization. We report several new findings in this study: correlations of EEG markers of synchronization with specific motor signs of Parkinson's disease (PD), and demonstration that one of the EEG markers, phase-amplitude coupling, is more elevated over the more clinically affected brain hemisphere. These findings underscore the potential utility of scalp EEG for objective, noninvasive monitoring of medication state in PD.

Entities:  

Keywords:  Parkinson’s disease; electroencephalography; levodopa; phase-amplitude coupling

Mesh:

Substances:

Year:  2019        PMID: 31066605      PMCID: PMC6689788          DOI: 10.1152/jn.00141.2019

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  40 in total

Review 1.  Circuits and circuit disorders of the basal ganglia.

Authors:  Mahlon R DeLong; Thomas Wichmann
Journal:  Arch Neurol       Date:  2007-01

2.  Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease.

Authors:  Andrew I Yang; Nora Vanegas; Codrin Lungu; Kareem A Zaghloul
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

3.  Cortico-cortical coupling in Parkinson's disease and its modulation by therapy.

Authors:  Paul Silberstein; Alek Pogosyan; Andrea A Kühn; Gary Hotton; Stephen Tisch; Andreas Kupsch; Patricia Dowsey-Limousin; Marwan I Hariz; Peter Brown
Journal:  Brain       Date:  2005-03-17       Impact factor: 13.501

4.  Evaluation of event-related desynchronization (ERD) preceding and following voluntary self-paced movement.

Authors:  G Pfurtscheller; A Aranibar
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1979-02

5.  Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.

Authors:  Daniel Weiss; Rosa Klotz; Rathinaswamy B Govindan; Marlieke Scholten; Georgios Naros; Ander Ramos-Murguialday; Friedemann Bunjes; Christoph Meisner; Christian Plewnia; Rejko Krüger; Alireza Gharabaghi
Journal:  Brain       Date:  2015-01-02       Impact factor: 13.501

6.  Nonsinusoidal Beta Oscillations Reflect Cortical Pathophysiology in Parkinson's Disease.

Authors:  Scott R Cole; Roemer van der Meij; Erik J Peterson; Coralie de Hemptinne; Philip A Starr; Bradley Voytek
Journal:  J Neurosci       Date:  2017-04-17       Impact factor: 6.167

7.  Real-Time Neuroimaging and Cognitive Monitoring Using Wearable Dry EEG.

Authors:  Tim R Mullen; Christian A E Kothe; Yu Mike Chi; Alejandro Ojeda; Trevor Kerth; Scott Makeig; Tzyy-Ping Jung; Gert Cauwenberghs
Journal:  IEEE Trans Biomed Eng       Date:  2015-09-23       Impact factor: 4.538

8.  High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance.

Authors:  Andrea A Kühn; Florian Kempf; Christof Brücke; Louise Gaynor Doyle; Irene Martinez-Torres; Alek Pogosyan; Thomas Trottenberg; Andreas Kupsch; Gerd-Helge Schneider; Marwan I Hariz; Wim Vandenberghe; Bart Nuttin; Peter Brown
Journal:  J Neurosci       Date:  2008-06-11       Impact factor: 6.167

Review 9.  Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders.

Authors:  C J Stam
Journal:  J Neurol Sci       Date:  2009-09-02       Impact factor: 3.181

10.  Characteristics of Waveform Shape in Parkinson's Disease Detected with Scalp Electroencephalography.

Authors:  Nicko Jackson; Scott R Cole; Bradley Voytek; Nicole C Swann
Journal:  eNeuro       Date:  2019-06-05
View more
  7 in total

Review 1.  Physiological Recordings of the Cerebellum in Movement Disorders.

Authors:  Ami Kumar; Chih-Chun Lin; Sheng-Han Kuo; Ming-Kai Pan
Journal:  Cerebellum       Date:  2022-09-07       Impact factor: 3.648

2.  Identification of an early-stage Parkinson's disease neuromarker using event-related potentials, brain network analytics and machine-learning.

Authors:  Sharon Hassin-Baer; Oren S Cohen; Simon Israeli-Korn; Gilad Yahalom; Sandra Benizri; Daniel Sand; Gil Issachar; Amir B Geva; Revital Shani-Hershkovich; Ziv Peremen
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

3.  The Effects of Non-Invasive Brain Stimulation on Quantitative EEG in Patients With Parkinson's Disease: A Systematic Scoping Review.

Authors:  Thaísa Dias de Carvalho Costa; Clécio Godeiro Júnior; Rodrigo Alencar E Silva; Silmara Freitas Dos Santos; Daniel Gomes da Silva Machado; Suellen Marinho Andrade
Journal:  Front Neurol       Date:  2022-03-02       Impact factor: 4.003

4.  Dopaminergic Modulation of Local Non-oscillatory Activity and Global-Network Properties in Parkinson's Disease: An EEG Study.

Authors:  Juanli Zhang; Arno Villringer; Vadim V Nikulin
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.750

5.  Cross-frequency phase-amplitude coupling in repetitive movements in patients with Parkinson's disease.

Authors:  Ruxue Gong; Christoph Mühlberg; Mirko Wegscheider; Christopher Fricke; Jost-Julian Rumpf; Thomas R Knösche; Joseph Classen
Journal:  J Neurophysiol       Date:  2022-05-11       Impact factor: 2.974

6.  Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson's Disease.

Authors:  Kevin Novak; Bruce A Chase; Jaishree Narayanan; Premananda Indic; Katerina Markopoulou
Journal:  Front Aging Neurosci       Date:  2022-01-03       Impact factor: 5.750

7.  Magnetoencephalography detects phase-amplitude coupling in Parkinson's disease.

Authors:  Masataka Tanaka; Takufumi Yanagisawa; Ryohei Fukuma; Naoki Tani; Satoru Oshino; Masahito Mihara; Noriaki Hattori; Yuta Kajiyama; Ryota Hashimoto; Manabu Ikeda; Hideki Mochizuki; Haruhiko Kishima
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.